跳至主要内容
临床试验/NCT07352410
NCT07352410已完成不适用

Safety and Early Clinical Performance of High-Purity Type I Collagen Augmentation in Arthroscopic Meniscal Repair: A Prospective Feasibility Study

Adichunchanagiri Institute of Medical Sciences, B G Nagara1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2026年1月3日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1

研究概览

简要总结

This prospective, single-arm feasibility study evaluates the safety, procedural feasibility, and early clinical outcomes of High-Purity Type I Collagen used as an adjunct in arthroscopic meniscal repair. The study aims to generate preliminary clinical, functional, and imaging data to inform the design of a future randomized controlled trial.

详细描述

Meniscal preservation is critical for long-term knee joint health, yet healing failure remains a concern, particularly in avascular zones. High-Purity Type I Collagen serves as a bioactive scaffold promoting cellular migration and early tissue integration. This study assesses early safety signals, feasibility metrics, patient-reported outcomes, and MRI-based healing characteristics following collagen-augmented meniscal repair.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 55 years
  • Symptomatic meniscal tear confirmed on MRI and indicated for arthroscopic repair
  • Tear patterns amenable to repair
  • Stable knee or concomitant ACL reconstruction permitted
  • Ability to comply with rehabilitation and follow-up
  • Written informed consent provided

排除标准

  • Advanced knee osteoarthritis (Kellgren-Lawrence grade ≥3)
  • Irreparable meniscal tears requiring meniscectomy
  • Active joint infection or inflammatory arthritis
  • Prior surgical repair of the index meniscus
  • Known hypersensitivity to collagen products
  • Systemic conditions impairing wound healing

研究者

发起方
Adichunchanagiri Institute of Medical Sciences, B G Nagara
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验